UTI MNC Fund Regular Plan-Growth - Returns, Rating & Analysis | Ionic Wealth
UTI MNC Fund Regular Plan-Growth
Equity
Thematic-MNC
₹-0.56% 1D
NAV on
AI Summary
Chart
Overview
Returns
Asset Allocation
Fund Info
Risk & Return Ratio
Fund Summary
Ionic AI
Loading...
Fund Overview
Rating
Not Rated
Minimum Investment
₹5000
NAV (Net Asset Value)
₹N/A
AUM (Fund size)
₹2663 Cr
Created on
N/A
Fund Ranking
#2
/ 4 in Thematic-MNC
Risk Level
Very High
Very High
Returns
Trailing Return
Rolling Return
6 Month
-5.1%
1 Year
1.3%
3 Year (CAGR)
10.1%
All Time (CAGR)
15.0%
Category Return
6 Month
1.2%
1 Year
7.7%
3 Year (CAGR)
9.8%
All Time (CAGR)
-
Asset Allocation
Equity
93.6%
Debt
0.4%
Other
6.0%
Top 5 Holdings
Top 5 Sectors
Hexaware Technologies
0.12%
Astrazeneca Pharma India
0.65%
Aurobindo Pharma
1.30%
Balkrishna Industries
0.82%
Bayer CropScience
0.19%
Fund Information
Expense Ratio
2.48%
Exit Load
Exit load of 1% if redeemed less than 1 year
Lock-In Period
No Lock-In
Managed By
Karthikraj Lakshmanan
Nov 2022 - Present
Risk & Return Ratio
Sharpe Ratio
Sharpe Ratio evaluates a fund's return relative to its risk. Higher values signify better risk-adjusted performance.
0.37
Standard Deviation
Standard deviation measures the volatility of a fund's returns. The higher the value, the riskier the investment.
14.76
Alpha
Alpha in mutual funds measures excess return relative to a benchmark, indicating a manager's skill at generating returns beyond market performance.
-1.73
Beta
Beta in mutual funds indicates a fund's sensitivity to market changes. A beta over 1 means it's more volatile than the market, while below 1 implies less volatility.